Source: International Congress 2019 – Tuberculosis: diagnosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Shepelkova (Moscow, Russian Federation), V. Evstifeev (Moscow, Russian Federation), A. Ergesheva (Moscow, Russian Federation), A. Guskov (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation). Lung microRNAs as biomarkers of post primary TB variants.. 3012

Member's Comments

Andi Muh Aunul Khaliq Gunawan - 24.04.2022 05:27
Can we get full text from this research ?

Related content which might interest you: Lung cancer biomarkers based on miRNA Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 MicroRNAs in serum of post primary TB patients. Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Differential microRNA expression in plasma of patients with pulmonary tuberculosis Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP) Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy Year: 2013 Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Identifying a tissue specific microRNA molecular signature in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Micro-RNA screening in neuroendocrine lung tumors: Differential expression of miR-29 family members Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Which gene expression signatures in pharmacogenomic strategies for lung cancer? Source: Annual Congress 2010 - Customised chemotherapy for lung cancer Year: 2010 Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 LATE-BREAKING ABSTRACT: Genome-wide association studies identify novel loci associated with early postnatal lung function Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Cancer-associated oncogenic BARD1 isoforms: From biomarker expression studies to development of a blood test for early detection of lung cancer Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012 Early detection of lung cancer in exhaled breath condensate using miRNA markers Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010